Cargando…

Radioembolization of Hepatocellular Carcinoma with Built-In Dosimetry: First in vivo Results with Uniformly-Sized, Biodegradable Microspheres Labeled with (188)Re

A common form of treatment for patients with hepatocellular carcinoma (HCC) is transarterial radioembolization (TARE) with non-degradable glass or resin microspheres (MS) labeled with (90)Y ((90)Y-MS). To further simplify the dosimetry calculations in the clinical setting, to have more control over...

Descripción completa

Detalles Bibliográficos
Autores principales:	De La Vega, José Carlos, Esquinas, Pedro Luis, Rodríguez-Rodríguez, Cristina, Bokharaei, Mehrdad, Moskalev, Igor, Liu, David, Saatchi, Katayoun, Häfeli, Urs O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376476/ https://www.ncbi.nlm.nih.gov/pubmed/30809314 http://dx.doi.org/10.7150/thno.29381

Ejemplares similares

Biodistribution, pharmacokinetics, and organ-level dosimetry for (188)Re-AHDD-Lipiodol radioembolization based on quantitative post-treatment SPECT/CT scans
por: Esquinas, Pedro L., et al.
Publicado: (2018)

Internal dosimetry for radioembolization therapy with Yttrium‐90 microspheres
por: Fallahpoor, Maryam, et al.
Publicado: (2017)

Process and formulation variables in the preparation of injectable and biodegradable magnetic microspheres
por: Zhao, Hong, et al.
Publicado: (2007)

Standardizing SPECT/CT dosimetry following radioembolization with yttrium-90 microspheres
por: Kim, S. Peter, et al.
Publicado: (2021)

Refinement and validation of infrared thermal imaging (IRT): a non-invasive technique to measure disease activity in a mouse model of rheumatoid arthritis
por: Nosrati, Zeynab, et al.
Publicado: (2020)

Quantitative Evaluation of a Multimodal Aptamer-Targeted Long-Circulating Polymer for Tumor Targeting
por: Bohrmann, Lennart, et al.
Publicado: (2023)

Comparison of Rhenium and Iodine as Contrast Agents in X-Ray Imaging
por: De La Vega, José Carlos, et al.
Publicado: (2021)

A Comparison of Techniques for (90)Y PET/CT Image-Based Dosimetry Following Radioembolization with Resin Microspheres
por: Pasciak, Alexander S., et al.
Publicado: (2014)

Post-treatment three-dimensional voxel-based dosimetry after Yttrium-90 resin microsphere radioembolization in HCC
por: Veenstra, Emile B., et al.
Publicado: (2022)

Precision dosimetry in yttrium-90 radioembolization through CT imaging of radiopaque microspheres in a rabbit liver model
por: Henry, E. Courtney, et al.
Publicado: (2022)

Initial Study of Radiological and Clinical Efficacy Radioembolization Using (188)Re-Human Serum Albumin (HSA) Microspheres in Patients with Progressive, Unresectable Primary or Secondary Liver Cancers
por: Nowicki, Mirosław L., et al.
Publicado: (2014)

Aptamers used for molecular imaging and theranostics - recent developments
por: Bohrmann, Lennart, et al.
Publicado: (2022)

Post-radioembolization yttrium-90 PET/CT - part 2: dose-response and tumor predictive dosimetry for resin microspheres
por: Kao, Yung-Hsiang, et al.
Publicado: (2013)

Inter-observer variability of (90)Y PET/CT dosimetry in hepatocellular carcinoma after glass microspheres transarterial radioembolization
por: Meyers, Nicolas, et al.
Publicado: (2020)

Pre- and post-treatment image-based dosimetry in (90)Y-microsphere radioembolization using the TOPAS Monte Carlo toolkit
por: Bertolet, Alejandro, et al.
Publicado: (2021)

Correction: Precision dosimetry in yttrium-90 radioembolization through CT imaging of radiopaque microspheres in a rabbit liver model
por: Henry, E. Courtney, et al.
Publicado: (2023)

Retrospective SPECT/CT dosimetry following transarterial radioembolization
por: Thompson, Briana C., et al.
Publicado: (2021)

Potential of Nuclear Imaging Techniques to Study the Oral Delivery of Peptides
por: Saxena, Tanya, et al.
Publicado: (2022)

Neutron-activated biodegradable samarium-153 acetylacetonate-poly-L-lactic acid microspheres for intraarterial radioembolization of hepatic tumors
por: Wong, Yin-How, et al.
Publicado: (2020)

(188)Re-SSS Lipiodol Radioembolization in HCC Patients: Results of a Phase 1 Trial (Lip-Re-01 Study)
por: Garin, Etienne, et al.
Publicado: (2023)

Clinical impact of (99m)Tc-MAA SPECT/CT-based dosimetry in the radioembolization of liver malignancies with (90)Y-loaded microspheres
por: Garin, Etienne, et al.
Publicado: (2015)

Automatic healthy liver segmentation for holmium-166 radioembolization dosimetry
por: Stella, Martina, et al.
Publicado: (2023)

Facile Preparation of Samarium Carbonate-Polymethacrylate Microspheres as a Neutron-Activatable Radioembolic Agent for Hepatic Radioembolization
por: Wong, Yin How, et al.
Publicado: (2023)

Dual-Isotope SPECT/CT Imaging of the Tuberculosis Subunit Vaccine H56/CAF01: Induction of Strong Systemic and Mucosal IgA and T-Cell Responses in Mice Upon Subcutaneous Prime and Intrapulmonary Boost Immunization
por: Thakur, Aneesh, et al.
Publicado: (2018)

Transarterial Radioembolization (TARE) Agents beyond (90)Y-Microspheres
por: Bouvry, C., et al.
Publicado: (2018)

Microspheres Used in Liver Radioembolization: From Conception to Clinical Effects
por: d’Abadie, Philippe, et al.
Publicado: (2021)

Economic evaluations of radioembolization with Itrium-90 microspheres in hepatocellular carcinoma: a systematic review
por: Alonso, J. C., et al.
Publicado: (2022)

Simplification of dosimetry in (90)Y-radioembolization therapy by dual planar images
por: Abuqbeitah, Mohammad, et al.
Publicado: (2022)

Radioembolization of Hepatocellular Carcinoma with (90)Y Glass Microspheres: No Advantage of Voxel Dosimetry with Respect to Mean Dose in Dose–Response Analysis with Two Radiological Methods
por: Romanò, Chiara, et al.
Publicado: (2022)

EANM dosimetry committee series on standard operational procedures: a unified methodology for (99m)Tc-MAA pre- and (90)Y peri-therapy dosimetry in liver radioembolization with (90)Y microspheres
por: Chiesa, Carlo, et al.
Publicado: (2021)

A phase 0 study of the pharmacokinetics, biodistribution, and dosimetry of (188)Re-liposome in patients with metastatic tumors
por: Wang, Shyh-Jen, et al.
Publicado: (2019)

Yttrium-90 Microsphere Radioembolization for Treatment of Lung Cancer Hepatic Metastases
por: Gaba, Ron C., et al.
Publicado: (2012)

Successful Yttrium-90 Microsphere Radioembolization for Hepatic Metastases of Prostate Cancer
por: Bunck, Alexander C., et al.
Publicado: (2017)

Optimization of the Clinical Effectiveness of Radioembolization in Hepatocellular Carcinoma with Dosimetry and Patient-Selection Criteria
por: d’Abadie, Philippe, et al.
Publicado: (2022)

Economic evaluations of radioembolization with yttrium-90 microspheres in liver metastases of colorectal cancer: a systematic review
por: Alonso, JC, et al.
Publicado: (2023)

Impact of the dosimetry approach on the resulting (90)Y radioembolization planned absorbed doses based on (99m)Tc-MAA SPECT-CT: is there agreement between dosimetry methods?
por: Morán, Verónica, et al.
Publicado: (2020)

Gastrectomy for the treatment of refractory gastric ulceration after radioembolization with (90)Y microspheres
por: Yim, Sun Young, et al.
Publicado: (2014)

Advances in SPECT for Optimizing the Liver Tumors Radioembolization Using Yttrium-90 Microspheres
por: Roshan, Hoda Rezaei, et al.
Publicado: (2015)

Radiometal-Labeled Chitosan Microspheres as Transarterial Radioembolization Agents against Hepatocellular Carcinoma
por: Chan, Hui-Wen, et al.
Publicado: (2022)

Phantom validation of quantitative Y-90 PET/CT-based dosimetry in liver radioembolization
por: D’Arienzo, Marco, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_nbiemfqa10to8vv64katjksimj